Committee for Orphan Medicinal Products (COMP): 2-3 February 2010
EventHumanRare diseases
Latvian is available via eTranslation, the European Commission's machine translation service.
Translate to Latvian | Important information about machine translation
Date
- Otrdiena, 2 Februāris 2010, Visu dienu
Vieta
- European Medicines Agency, Amsterdam, the Netherlands
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases. It does not currently publish the minutes or agendas of its meetings. It does publish a meeting report after each meeting.